vs
Side-by-side financial comparison of Koppers Holdings Inc. (KOP) and Bio-Techne (TECH). Click either name above to swap in a different company.
Koppers Holdings Inc. is the larger business by last-quarter revenue ($432.7M vs $295.9M, roughly 1.5× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 6.9%, a 6.0% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -9.3%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -6.7%).
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
KOP vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $432.7M | $295.9M |
| Net Profit | $29.7M | $38.0M |
| Gross Margin | 25.6% | 64.6% |
| Operating Margin | 11.5% | 18.4% |
| Net Margin | 6.9% | 12.8% |
| Revenue YoY | -9.3% | -6.4% |
| Net Profit YoY | 391.2% | 68.3% |
| EPS (diluted) | $1.44 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $432.7M | $295.9M | ||
| Q3 25 | $485.3M | — | ||
| Q2 25 | $504.8M | $317.0M | ||
| Q1 25 | $456.5M | $316.2M | ||
| Q4 24 | $477.0M | $297.0M | ||
| Q3 24 | $554.3M | $289.5M | ||
| Q2 24 | $563.2M | $306.1M | ||
| Q1 24 | $497.6M | $303.4M |
| Q4 25 | $29.7M | $38.0M | ||
| Q3 25 | $23.8M | — | ||
| Q2 25 | $16.4M | $-17.7M | ||
| Q1 25 | $-13.9M | $22.6M | ||
| Q4 24 | $-10.2M | $34.9M | ||
| Q3 24 | $22.8M | $33.6M | ||
| Q2 24 | $26.8M | $40.6M | ||
| Q1 24 | $13.0M | $49.1M |
| Q4 25 | 25.6% | 64.6% | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.6% | 62.7% | ||
| Q1 25 | 23.2% | 67.9% | ||
| Q4 24 | 17.5% | 65.3% | ||
| Q3 24 | 21.9% | 63.2% | ||
| Q2 24 | 21.6% | 66.4% | ||
| Q1 24 | 19.3% | 67.4% |
| Q4 25 | 11.5% | 18.4% | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 7.7% | -7.5% | ||
| Q1 25 | 5.9% | 12.2% | ||
| Q4 24 | 1.3% | 16.0% | ||
| Q3 24 | 9.0% | 13.8% | ||
| Q2 24 | 10.2% | 15.0% | ||
| Q1 24 | 7.0% | 22.1% |
| Q4 25 | 6.9% | 12.8% | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 3.2% | -5.6% | ||
| Q1 25 | -3.0% | 7.1% | ||
| Q4 24 | -2.1% | 11.7% | ||
| Q3 24 | 4.1% | 11.6% | ||
| Q2 24 | 4.8% | 13.3% | ||
| Q1 24 | 2.6% | 16.2% |
| Q4 25 | $1.44 | $0.24 | ||
| Q3 25 | $1.17 | — | ||
| Q2 25 | $0.81 | $-0.11 | ||
| Q1 25 | $-0.68 | $0.14 | ||
| Q4 24 | $-0.47 | $0.22 | ||
| Q3 24 | $1.09 | $0.21 | ||
| Q2 24 | $1.25 | $0.26 | ||
| Q1 24 | $0.59 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | $928.3M | $260.0M |
| Stockholders' EquityBook value | $574.0M | $2.0B |
| Total Assets | $1.9B | $2.5B |
| Debt / EquityLower = less leverage | 1.62× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | $928.3M | $260.0M | ||
| Q3 25 | $932.9M | — | ||
| Q2 25 | $977.5M | $346.0M | ||
| Q1 25 | $989.0M | $330.0M | ||
| Q4 24 | $939.5M | $300.0M | ||
| Q3 24 | $989.4M | $300.0M | ||
| Q2 24 | $1.0B | $319.0M | ||
| Q1 24 | $877.6M | $389.0M |
| Q4 25 | $574.0M | $2.0B | ||
| Q3 25 | $545.6M | — | ||
| Q2 25 | $526.8M | $1.9B | ||
| Q1 25 | $498.0M | $2.0B | ||
| Q4 24 | $488.7M | $2.1B | ||
| Q3 24 | $532.3M | $2.1B | ||
| Q2 24 | $509.2M | $2.1B | ||
| Q1 24 | $505.8M | $2.0B |
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | $2.6B | ||
| Q1 25 | $1.9B | $2.6B | ||
| Q4 24 | $1.9B | $2.7B | ||
| Q3 24 | $2.0B | $2.7B | ||
| Q2 24 | $1.9B | $2.7B | ||
| Q1 24 | $1.8B | $2.7B |
| Q4 25 | 1.62× | 0.13× | ||
| Q3 25 | 1.71× | — | ||
| Q2 25 | 1.86× | 0.18× | ||
| Q1 25 | 1.99× | 0.16× | ||
| Q4 24 | 1.92× | 0.14× | ||
| Q3 24 | 1.86× | 0.14× | ||
| Q2 24 | 1.97× | 0.15× | ||
| Q1 24 | 1.74× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.1M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | 1.52× | — |
| TTM Free Cash FlowTrailing 4 quarters | $67.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | — | ||
| Q3 25 | $49.6M | — | ||
| Q2 25 | $50.5M | $98.2M | ||
| Q1 25 | $-22.7M | $41.1M | ||
| Q4 24 | $74.7M | $84.3M | ||
| Q3 24 | $29.8M | $63.9M | ||
| Q2 24 | $27.2M | $75.5M | ||
| Q1 24 | $-12.3M | $81.0M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $37.6M | — | ||
| Q2 25 | $38.4M | $93.3M | ||
| Q1 25 | $-37.0M | $31.0M | ||
| Q4 24 | $56.1M | $77.5M | ||
| Q3 24 | $14.4M | $54.7M | ||
| Q2 24 | $10.1M | $57.5M | ||
| Q1 24 | $-38.6M | $64.5M |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.6% | 29.4% | ||
| Q1 25 | -8.1% | 9.8% | ||
| Q4 24 | 11.8% | 26.1% | ||
| Q3 24 | 2.6% | 18.9% | ||
| Q2 24 | 1.8% | 18.8% | ||
| Q1 24 | -7.8% | 21.3% |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.4% | 1.5% | ||
| Q1 25 | 3.1% | 3.2% | ||
| Q4 24 | 3.9% | 2.3% | ||
| Q3 24 | 2.8% | 3.2% | ||
| Q2 24 | 3.0% | 5.9% | ||
| Q1 24 | 5.3% | 5.4% |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 3.08× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 1.31× | 1.90× | ||
| Q2 24 | 1.01× | 1.86× | ||
| Q1 24 | -0.95× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
